A comparison of COVID-19 and post-COVID-19 syndrome among symptomatic and asymptomatic patients in Bangladesh: A retrospective cohort study

被引:0
作者
Bhowmik, Leon [1 ]
Hasan, Md Kutubul [1 ]
Bristy, Tahmina Akter [1 ]
Etu, Sadia Tasnim [1 ]
Karim, Reatul [1 ]
Mostaid, Md Shaki [1 ]
Shill, Manik Chandra [1 ]
Reza, Hasan Mahmud [1 ]
机构
[1] North South Univ, Dept Pharmaceut Sci, Dhaka, Bangladesh
关键词
COVID-19; post-COVID-19; Symptomatic; Asymptomatic; Risk factors;
D O I
10.1016/j.heliyon.2024.e36202
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: The differentiation between COVID-19 and post-COVID-19 syndromes is not properly defined as some patients remain asymptomatic for post-COVID-19. It can be characterized by several signs and symptoms. Risk factors related to post-COVID-19 remain unsolved. Here we aimed to differentiate post-COVID-19 patients among symptomatic and asymptomatic groups to check the percentage among them and the risk factors for post-COVID-19 and the association of different symptoms. Methods: This study was conducted in Chittagong division, Bangladesh at different hospitals. Data were collected from the participants either by in person interview or online (email) or mobile phone calls. Follow up was done after 3 months to check the development of post-COVID-19 syndromes. Relevant data were taken, and symptomatic and asymptomatic patients were divided based on the presence and severity of specific symptoms. Results: Our results showed that 41.88 % patients develop post-COVID-19 symptoms. Fever and Cough were classified as one of the factors of post-COVID-19, followed by dyspnea, fatigue, cough, rhinitis, sore throat, and muscular discomfort. On the other hand, age, respiratory distress, lethargy, duration of illness and severity were classified as risk factors for post-COVID-19. There was a significant difference between symptomatic and asymptomatic patients as only 16.3 % patients showed post-COVID-19 symptoms. Based on the severity grade, 80.7 % of patients had mild COVID-19. We also found that people with 'B' positive blood group had a higher chance of developing post-COVID-19 syndrome. Conclusion: It was concluded that age, duration of illness, presence of respiratory distress, blood group, and disease severity are major risk factors for the development of post-COVID-19 syndrome.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Post COVID-19 complications and follow up biomarkers
    Abdullah, Muhammad
    Ali, Amjed
    Usman, Muhammad
    Naz, Anam
    Qureshi, Javed Anver
    Bajaber, Majed A.
    Zhang, Xiao
    [J]. NANOSCALE ADVANCES, 2023, 5 (21): : 5705 - 5716
  • [2] High-dimensional characterization of post-acute sequelae of COVID-19
    Al-Aly, Ziyad
    Xie, Yan
    Bowe, Benjamin
    [J]. NATURE, 2021, 594 (7862) : 259 - +
  • [3] Causation or confounding: why controls are critical for characterizing long COVID
    Amin-Chowdhury, Zahin
    Ladhani, Shamez N.
    [J]. NATURE MEDICINE, 2021, 27 (07) : 1129 - 1130
  • [4] [Anonymous], 2020, LANCET, V396, P1861, DOI 10.1016/S0140-6736(20)32662-3
  • [5] Understanding the long-term health effects of COVID-19
    不详
    [J]. ECLINICALMEDICINE, 2020, 26
  • [6] [Anonymous], 2020, Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance
  • [7] [Anonymous], Clinical spectrum|COVID-19 treatment guidelines
  • [8] [Anonymous], Managing and Overcoming Post-COVID Fatigue
  • [9] [Anonymous], CORONAVIRUS DIS COVI
  • [10] Female gender is associated with long COVID syndrome: a prospective cohort study
    Bai, Francesca
    Tomasoni, Daniele
    Falcinella, Camilla
    Barbanotti, Diletta
    Castoldi, Roberto
    Mule, Giovanni
    Augello, Matteo
    Mondatore, Debora
    Allegrini, Marina
    Cona, Andrea
    Tesoro, Daniele
    Tagliaferri, Gianmarco
    Vigano, Ottavia
    Suardi, Elisa
    Tincati, Camilla
    Beringheli, Tomaso
    Varisco, Benedetta
    Battistini, Chiara Luridiana
    Piscopo, Kyrie
    Vegni, Elena
    Tavelli, Alessandro
    Terzoni, Stefano
    Marchetti, Giulia
    Monforte, Antonella D'Arminio
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (04) : 611.e9 - 611.e16